Using a synthetic fiber matrix to improve healing of surgical wounds from skin cancer removal

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the effectiveness of a synthetic electrospun fiber matrix in promoting wound healing for patients undergoing surgical resection of malignant skin tumors. Participants will have their surgical wounds treated with this innovative material, and the study will measure the time taken for the wounds to achieve complete granulation. The focus is on understanding how this treatment can enhance recovery outcomes in a specific patient population. The study will involve patients aged 18 and older who meet specific eligibility criteria related to their surgical wounds.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient is at least 18 years old
2. Patient plans to undergo surgical resection of a cutaneous neoplasm
3. Patient is willing and capable of complying with all protocol requirements
4. Patient or legally authorized representative (LAR) is willing to provide written informed consent prior to participation in study
5. Post-resection surgical wound with a surface area of ≥4 cm2 and ≤ 36cm2

Exclusion Criteria:

1. Inability to give informed consent or to complete the procedures required for study completion
2. Patient has been previously enrolled into this study, or is currently participating in another drug or device study that has not reached its primary endpoint
3. Patient is pregnant, breast feeding or planning to become pregnant
4. Patient has a known allergy to resorbable suture materials, e.g. Polyglactin 910 (PGLA), Polydioxanone (PDS)
5. Patients receiving any immunotherapy, radiation, or chemotherapy within the past four weeks prior to resection surgery.
6. Patient has a life expectancy less than six months as assessed by the investigator
7. Patient has an additional non-study related wound within 3 cm of the study wound
8. Study wound is located on the hands or feet
9. Patient has been diagnosed with osteomalacia
10. Resection defect from a squamous cell carcinoma arising from a chronic wound
11. Patient has an uncontrolled thyroid disorder
12. Hgb A1c \> 12% within 3 months prior to enrollment in patients with a known history of diabetes
13. Patient has a BMI \> 34.9
14. Patient has used any tobacco product within the past 30 days prior to surgery
15. Patients with chronic kidney disease on peritoneal or hemodialysis, or with an estimated glomerular filtration rate less than 15mL/min
16. Patients with severe liver disease with active cirrhosis defined as a gross ascites upon clinical exam or a Model for End-stage Liver Disease (MELD)-Na score greater than 15
17. Patient not in reasonable metabolic control in the judgement of the investigator
18. Patient has a known history of poor compliance with medical treatment
19. Patient has a history of radiotherapy to wound bed of interest
20. Patient has been diagnosed with at least one of the following autoimmune connective tissue diseases: lupus, vasculitis, sickle cell, or uncontrolled rheumatoid arthritis
21. Active infection, undrained abscess, or critical colonization of the wound with bacteria in the judgement of the investigator

Where it's running

• University Nevada - Las Vegas
  Las Vegas, Nevada, United States Recruiting

Study contacts

• Study coordinator: Matthew MacEwan, PhD
• Email: macewan@acera-surgical.com
• Phone: 440-477-1890

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• SupraSDRM vs standard dressing for full-thickness wounds requiring grafting

  This study tests whether SupraSDRM® helps healing faster and makes skin grafting possible sooner in adults with full-thickness wounds compared to standard wound dressings.

  Recruiting The Metis Foundation · Fort Sam Houston, Texas · NCT06503406

• Comparing early and delayed bathing for orthopedic surgical wounds

  This study tests whether letting patients bathe early or waiting longer after orthopedic surgery for fractures affects their satisfaction and the risk of infections.

  Recruiting Hospital for Special Surgery, New York · New York, New York · NCT06014411

• Comparing saline irrigation and povidone-iodine for preventing infections in emergency surgeries

  This study is testing whether using saline irrigation or a povidone-iodine solution before closing surgical incisions can better prevent infections in patients having emergency surgeries.

  Recruiting Phase 2/3 Dow University of Health Sciences · Karachi, Sindh · NCT05989386

• Comparing 7-day and 14-day wound dressings for revision hip and knee surgeries

  This study is testing whether using a wound dressing for 7 days or 14 days helps people heal better after hip and knee revision surgeries.

  Recruiting Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust · Oswestry, Shropshire · NCT05389410

• Evaluating pain pathways and nerve regeneration in keratoconus patients after corneal crosslinking

  This study is testing how corneal crosslinking affects pain and nerve healing in people with keratoconus to see how their pain changes over time.

  Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT04439552

• Using Oasis ECM to treat donor site wounds

  This study is testing if a new treatment called Oasis ECM can help heal donor site wounds better than regular wound care for people over 16 in the UK.

  Recruiting Cook Biotech Incorporated · Manchester, England · NCT04079348

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.